Literature DB >> 30648603

Determination of Escherichia coli phylogroups in elderly patients with urinary tract infection or asymptomatic bacteriuria.

R Amarsy1, D Guéret2, H Benmansour3, R Flicoteaux4, B Berçot5, F Meunier3, F Mougari5, H Jacquier5, G Pean de Ponfilly3, O Clermont6, E Denamur6, A Teixeira7, E Cambau8.   

Abstract

OBJECTIVES: Distinguishing between urinary tract infection (UTI) and asymptomatic bacteriuria (ABU) is difficult in the geriatric population since specific symptoms are often lacking. Escherichia coli is the most frequent UTI pathogen in this population but also a common urine colonizer. We hypothesized that detecting E. coli phylogroups B2 or D, which were previously associated with virulent strains responsible for extra-intestinal infections outside elderly patients, could help in distinguishing UTI from ABU.
METHODS: Consecutive cases of E. coli bacteriuria diagnosed in hospitalized patients >75 years old during 3 months were investigated for E. coli phylogroups. Multiplex PCR was used to search for several virulence genes as previously described. Characteristics of UTI and ABU cases, assessed retrospectively according to definitions and geriatric expertise, were compared.
RESULTS: Out of 233 bacteriuria cases, 60 were assessed to be UTI and 163 to be ABU, with 10 cases unclassified. E. coli strains belonging to the phylogroups B2 and D were significantly more frequent in UTI (48/60, 80%) than in ABU (101/163, 62%) by univariate and multivariate analyses (OR 3.05, 1.44-6.86, p 0.005). Out of all the host and bacterial characteristics studied, falls (p 0.032), comorbidities (p 0.041), and altered autonomy evaluated by a low activity of daily living score (p 0.027) were also associated with UTI using univariate and multivariate analysis.
CONCLUSIONS: Determination of the E. coli phylogroup, in addition to some host characteristics, can help to distinguish UTI from ABU in elderly patients with bacteriuria. If this hypothesis is confirmed by prospective studies, then inappropriate use of antibiotics may be reduced in ABU cases.
Copyright © 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asymptomatic bacteriuria; Escherichia coli; Geriatric population; Multiplex PCR; Phylogroups B2 and D; Urinary tract infection; Virulence

Mesh:

Substances:

Year:  2019        PMID: 30648603     DOI: 10.1016/j.cmi.2018.12.032

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  4 in total

1.  A 21-Year Survey of Escherichia coli from Bloodstream Infections (BSI) in a Tertiary Hospital Reveals How Community-Hospital Dynamics of B2 Phylogroup Clones Influence Local BSI Rates.

Authors:  Irene Rodríguez; Ana Sofia Figueiredo; Melissa Sousa; Sonia Aracil-Gisbert; Miguel D Fernández-de-Bobadilla; Val F Lanza; Concepción Rodríguez; Javier Zamora; Elena Loza; Patricia Mingo; Claire J Brooks; Rafael Cantón; Fernando Baquero; Teresa M Coque
Journal:  mSphere       Date:  2021-12-22       Impact factor: 4.389

2.  Whole-Genome Sequencing and Virulome Analysis of Escherichia coli Isolated from New Zealand Environments of Contrasting Observed Land Use.

Authors:  Adrian L Cookson; Jonathan C Marshall; Patrick J Biggs; Lynn E Rogers; Rose M Collis; Megan Devane; Rebecca Stott; David A Wilkinson; Janine Kamke; Gale Brightwell
Journal:  Appl Environ Microbiol       Date:  2022-04-20       Impact factor: 5.005

3.  Identity of blaCTX-M Carrying Plasmids in Sequential ESBL-E. coli Isolates from Patients with Recurrent Urinary Tract Infections.

Authors:  Nahid Karami; Sriram Kk; Shora Yazdanshenas; Yii-Lih Lin; Daniel Jaén-Luchoro; Elina Ekedahl; Sanjana Parameshwaran; Anna Lindblom; Christina Åhrén; Fredrik Westerlund
Journal:  Microorganisms       Date:  2021-05-25

4.  "A false sense of confidence" The perceived role of inflammatory point-of-care testing in managing urinary tract infections in Dutch nursing homes: a qualitative study.

Authors:  S D Kuil; C Schneeberger; F van Leth; M D de Jong; J Harting
Journal:  BMC Geriatr       Date:  2020-11-04       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.